Part 2: Oligonucleotide therapeutic development: Pre-clinical and translational considerations On-Demand Webinar パート 2:Oligonucleotide therapeutic development: Pre-clinical and translational considerations In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…Jim Gallagher2021年4月21日
Part 1: What are oligonucleotide therapeutics, and how do they work? オンデマンド・ウェビナー パート1:What are oligonucleotide therapeutics, and how do they work? In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…Jim Gallagher2021年4月21日
Plan to Accelerate Your Time to Drug Submissions On-Demand Webinar 医薬品申請を加速させるための戦略を立案する方法 There are common themes driving how quickly you can get from your last database lock…Jim Gallagher2021年4月20日
A Best Practice Framework for Applying PBPK Modeling to Pediatric Drug Development On-Demand Webinar A Best Practice Framework for Applying PBPK Modeling to Pediatric Drug Development Pediatric PBPK models have broad application in the drug development process and are being used…Jim Gallagher2021年4月20日
Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure On-Demand Webinar Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure The European Medicines Agency (EMA) recently approved dulaglutide (Trulicity®) at higher doses (3 mg and…Jim Gallagher2021年4月1日
Strategic Evidence & Value Communication Symposium On-Demand Webinar Strategic Evidence & Value Communication Symposium Join us on 2021年4月21日 (水曜日), from12:00 PM – 2:00 PM EDT for Certara’s…Certara2021年3月26日
Purity is a Virtue: A Practical Guide to the Reporting of Impurities On-Demand Webinar Purity is a Virtue: 不純物報告に関する実践ガイド Many pharmaceutical companies struggle with characterizing drug substance (DS) and drug product (DP) impurities and…Certara2021年3月23日
IQ WG Evaluation of PBPK Models for Organ-Impaired Populations On-Demand Webinar IQ WG Evaluation of PBPK Models for Organ-Impaired Populations • The predictive performance of physiologically based pharmacokinetic(s) (PBPK) models for PK in renal impairment…Jim Gallagher2021年3月10日
Sealing Pharma Commercialization Deals: Creating Optimal Value for Investors On-Demand Webinar Sealing Pharma Commercialization Deals: Creating Optimal Value for Investors It is crucial for biotech developers to engage in early commercial market assessment to generate…Jim Gallagher2021年3月5日
Quantitative Systems Pharmacology for Drug Discovery and Development On-Demand Webinar Quantitative Systems Pharmacology for Drug Discovery and Development Certara's Dr. Piet van der Graaf, Senior Vice President, Professor of Systems Pharmacology, Leiden University,…Jim Gallagher2021年3月2日